Biomed Central Ltd

SHERPA: Unknown

People

  1. Vickers
    Vickers
  2. Postow
    Postow
  3. D'Angelo
    D'Angelo
  4. Offit
    Offit
  5. Budhu
    Budhu
  6. Motzer
    Motzer
  7. Cheung
    Cheung
  8. Voss
    Voss
  9. O'Reilly
    O'Reilly
  10. Robson
    Robson

Groups

  1. Department of Medicine (556)
  2. Solid Tumor Oncology Division (454)
  3. GSK Faculty (290)
  4. Sloan Kettering Institute Postdocs (193)
  5. Population Sciences Research Program (158)
  6. Hematologic Malignancies, Division of (152)
  7. Epidemiology and Biostatistics (151)
  8. Melanoma and Immunotherapeutics Service (148)
  9. Survivorship Research (121)
  10. Surgery (118)
Search Within
Formats
  1. Journal Article (745)
  2. Meeting Abstract (257)
  3. Review (40)
  4. Guidelines (20)
  5. Editorial (10)
  6. Research Letter (7)
  7. Correspondence (4)
  8. Conference Paper (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (556)
  2. Solid Tumor Oncology Division (454)
  3. GSK Faculty (290)
  4. Sloan Kettering Institute Postdocs (193)
  5. Population Sciences Research Program (158)
  6. Hematologic Malignancies, Division of (152)

More Groups

People
  1. Jedd Wolchok (83)
  2. Taha Merghoub (55)
  3. Andrew Vickers (44)
  4. Michael Postow (43)
  5. Matthew Hellmann (30)
  6. Roberta Zappasodi (24)

More People

Years
  1. 2025 (28)
  2. 2024 (63)
  3. 2023 (45)
  4. 2022 (123)
  5. 2021 (91)
  6. 2020 (99)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (404)
  2. Breast Cancer Research (67)
  3. BMC Cancer (64)
  4. Genome Biology (46)
  5. Journal of Hematology & Oncology (42)
  6. Journal of Translational Medicine (35)

More Publications

Results (1085)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067
    Journal Article

    Regan, M. M.; Mantia, C. M.; Werner, L.; Tarhini, A. A.; Larkin, J.; Hodi, F. S.; Wolchok, J.; Postow, M. A.; Stwalley, B.; Moshyk, A.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: A two-center observational study
    Journal Article

    Zou, F.; Faleck, D.; Thomas, A.; Harris, J.; Satish, D.; Wang, X.; Charabaty, A.; Ernstoff, M. S.; Glitza Oliva, I. C.; Hanauer, S.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Impact of tumor mutational burden on checkpoint inhibitor drug eligibility and outcomes across racial groups
    Journal Article

    Hsiehchen, D.; Espinoza, M.; Valero, C.; Ahn, C.; Morris, L. G. T.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Differentiation syndrome-induced myopericarditis in the induction therapy of acute promyelocytic leukemia: A case report
    Journal Article

    Shenoy, S. M.; Di Vitantonio, T.; Plitt, A.; Perez-Johnston, R.; Gutierrez, J.; Knorr, D. A.; Stein, E. M.; Liu, J. E.; Feldman, S.
    Cardio-Oncology (2021)

    Fulltext@MSK | Save
  • A protocol for developing a core outcome set for ectopic pregnancy
    Journal Article

    Chong, K. Y.; Solangon, S.; Kemper, J.; Barnhart, K.; Causa Andrieu, P.; Capmas, P.; Chacon, C.; Condous, G.; de Waard, L.; Duffy, J. M. N.; more...
    Trials (2021)

    Fulltext@MSK | Save
  • Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
    Journal Article

    Chapman, P. B.; Jayaprakasam, V. S.; Panageas, K. S.; Callahan, M.; Postow, M. A.; Shoushtari, A. N.; Wolchok, J. D.; Betof Warner, A.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Attributions of survival and methods of coping of long-term ovarian cancer survivors: A qualitative study
    Journal Article

    Ketcher, D.; Lutgendorf, S. K.; Leighton, S.; Matzo, M.; Carter, J.; Peddireddy, A.; Karlan, B. Y.; Tew, W. P.; Sood, A. K.; Shinn, E. H.
    BMC Women's Health (2021)

    Fulltext@MSK | Save
  • Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
    Journal Article

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Hasan, M. M.; Chavan, S. S.; Meng, F.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N. S.; more...
    Journal of Hematology & Oncology (2021)

    Fulltext@MSK | Save
  • PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma
    Journal Article

    Gibney, G. T.; Zaemes, J.; Shand, S.; Shah, N. J.; Swoboda, D.; Gardner, K.; Radfar, A.; Petronic-Rosic, V.; Reilly, M. J.; Al-Refaie, W. B.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Acute kidney injury in patients treated with immune checkpoint inhibitors
    Journal Article

    Gupta, S.; Short, S. A. P.; Sise, M. E.; Prosek, J. M.; Madhavan, S. M.; Soler, M. J.; Ostermann, M.; Herrmann, S. M.; Abudayyeh, A.; Anand, S.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save